The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
47
PERSONALIZED THERAPY FOR THE TREATMENT OF WEIGHT REGAIN FOLLOWING ROUX-EN-Y GASTRIC BYPASS: AN ANALYSIS OF 900 CONSECUTIVE ENDOSCOPIC REVISION PROCEDURES
Date
May 6, 2023
Explore related products in the following collection:
BACKGROUND: Hepatic encephalopathy (HE) is associated with increased mortality, falls, and frequent hospitalizations. Patient reported outcomes (PROs) are useful tools to assess health-related quality of life (HRQOL) measures such as impairment of sleep, cognition, or activity…
BACKGROUND: Malnutrition is a complication of Roux-en-Y gastric bypass (RYGB) and can range from micronutrient deficiencies to protein-calorie malnutrition. Malignant neoplasms and certain surgical complications can increase this risk…
BACKGROUND: Despite the advances in the multidisciplinary treatment of gastric adenocarcinoma, the overall 5-year survival remains only 33.3% in North America. R0 resection with adequate lymphadenectomy remains the mainstay therapy…